Used as an intermediate in organic synthesis, particularly in the development of pharmaceutical compounds targeting neurological and psychiatric disorders. Its structure supports the design of molecules with central nervous system activity, including potential antidepressants and cognitive enhancers. Commonly employed in research settings to explore structure-activity relationships in amine-based therapeutics. Also utilized in the preparation of ligands for receptor binding studies, especially related to monoaminergic systems.